| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |